Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, T. J. Martin

Research output: Contribution to journalReview article

1761 Citations (Scopus)

Abstract

and acts as a decoy receptor in the RANK-RANKL signaling system (Fig. 8). In conclusion, osteoblasts/stromal cells are involved in all of the processes of osteoclast development, such as differentiation, survival, fusion, and activation of osteoclasts (Fig. 8). Osteoblasts/stromal cells can now be replaced with RANKL and M-CSF in dealing with the whole life of osteoclasts. RANKL, RANK, and OPG are three key molecules that regulate osteoclast recruitment and function. Further studies on these key molecules will elucidate the molecular mechanism of the regulation of osteoclastic bone resorption. This line of studies will establish new ways to treat several metabolic bone diseases caused by abnormal osteoclast recruitment and functions such as osteopetrosis, osteoporosis, metastatic bone disease, Paget's disease, rheumatoid arthritis, and periodontal bone disease.

Original languageEnglish
Pages (from-to)345-357
Number of pages13
JournalEndocrine Reviews
Volume20
Issue number3
DOIs
Publication statusPublished - Jan 1 1999
Externally publishedYes

Fingerprint

Tumor Necrosis Factor Receptors
Osteoclasts
Ligands
Stromal Cells
Osteoblasts
Osteopetrosis
Osteitis Deformans
Macrophage Colony-Stimulating Factor
Metabolic Bone Diseases
Bone Diseases
Periodontal Diseases
Bone Resorption
Osteoporosis
Rheumatoid Arthritis

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. / Suda, T.; Takahashi, N.; Udagawa, N.; Jimi, E.; Gillespie, M. T.; Martin, T. J.

In: Endocrine Reviews, Vol. 20, No. 3, 01.01.1999, p. 345-357.

Research output: Contribution to journalReview article

Suda, T. ; Takahashi, N. ; Udagawa, N. ; Jimi, E. ; Gillespie, M. T. ; Martin, T. J. / Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. In: Endocrine Reviews. 1999 ; Vol. 20, No. 3. pp. 345-357.
@article{7ee0d58eb2c945d69588903b01ef3634,
title = "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families",
abstract = "and acts as a decoy receptor in the RANK-RANKL signaling system (Fig. 8). In conclusion, osteoblasts/stromal cells are involved in all of the processes of osteoclast development, such as differentiation, survival, fusion, and activation of osteoclasts (Fig. 8). Osteoblasts/stromal cells can now be replaced with RANKL and M-CSF in dealing with the whole life of osteoclasts. RANKL, RANK, and OPG are three key molecules that regulate osteoclast recruitment and function. Further studies on these key molecules will elucidate the molecular mechanism of the regulation of osteoclastic bone resorption. This line of studies will establish new ways to treat several metabolic bone diseases caused by abnormal osteoclast recruitment and functions such as osteopetrosis, osteoporosis, metastatic bone disease, Paget's disease, rheumatoid arthritis, and periodontal bone disease.",
author = "T. Suda and N. Takahashi and N. Udagawa and E. Jimi and Gillespie, {M. T.} and Martin, {T. J.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1210/edrv.20.3.0367",
language = "English",
volume = "20",
pages = "345--357",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

AU - Suda, T.

AU - Takahashi, N.

AU - Udagawa, N.

AU - Jimi, E.

AU - Gillespie, M. T.

AU - Martin, T. J.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - and acts as a decoy receptor in the RANK-RANKL signaling system (Fig. 8). In conclusion, osteoblasts/stromal cells are involved in all of the processes of osteoclast development, such as differentiation, survival, fusion, and activation of osteoclasts (Fig. 8). Osteoblasts/stromal cells can now be replaced with RANKL and M-CSF in dealing with the whole life of osteoclasts. RANKL, RANK, and OPG are three key molecules that regulate osteoclast recruitment and function. Further studies on these key molecules will elucidate the molecular mechanism of the regulation of osteoclastic bone resorption. This line of studies will establish new ways to treat several metabolic bone diseases caused by abnormal osteoclast recruitment and functions such as osteopetrosis, osteoporosis, metastatic bone disease, Paget's disease, rheumatoid arthritis, and periodontal bone disease.

AB - and acts as a decoy receptor in the RANK-RANKL signaling system (Fig. 8). In conclusion, osteoblasts/stromal cells are involved in all of the processes of osteoclast development, such as differentiation, survival, fusion, and activation of osteoclasts (Fig. 8). Osteoblasts/stromal cells can now be replaced with RANKL and M-CSF in dealing with the whole life of osteoclasts. RANKL, RANK, and OPG are three key molecules that regulate osteoclast recruitment and function. Further studies on these key molecules will elucidate the molecular mechanism of the regulation of osteoclastic bone resorption. This line of studies will establish new ways to treat several metabolic bone diseases caused by abnormal osteoclast recruitment and functions such as osteopetrosis, osteoporosis, metastatic bone disease, Paget's disease, rheumatoid arthritis, and periodontal bone disease.

UR - http://www.scopus.com/inward/record.url?scp=0033304730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033304730&partnerID=8YFLogxK

U2 - 10.1210/edrv.20.3.0367

DO - 10.1210/edrv.20.3.0367

M3 - Review article

C2 - 10368775

AN - SCOPUS:0033304730

VL - 20

SP - 345

EP - 357

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 3

ER -